144
Participants
Start Date
August 31, 2005
Primary Completion Date
June 30, 2007
Study Completion Date
June 30, 2007
Botulinum Toxin Type A
100 U up to 6 times during the study depending on the response to treatment
Portland
Vancouver
Lead Sponsor
Allergan
INDUSTRY